NCT04975503

Risk Factors in Young Middle Eastern Women With Cardiovascular Disease

Completed Last updated 30 January 2024

What this trial tests

trial testing Observing cardiovascular risk factors in Cardiovascular Diseases in 627 participants. Completed in 31 October 2023.

Timeline

22 August 2021

Primary endpoint
30 October 2023

31 October 2023

Quick facts

Lead sponsor	Jordan Collaborating Cardiology Group
Status	Completed
Study type	OBSERVATIONAL
Enrollment	627
Start date	22 August 2021
Primary completion	30 October 2023
Estimated completion	31 October 2023
Sites	1 location across Jordan

Drugs / interventions tested

• Observing cardiovascular risk factors

Conditions studied

• Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
• Risk Factors — all drugs for Risk Factors →

Sponsor

Jordan Collaborating Cardiology Group — full company profile →

Who can join

18 and older, female only, with Cardiovascular Diseases or Risk Factors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiovascular disease continues to be the leading cause of death among women in the Middle East, including Jordan. Sex-specific data focused on cardiovascular disease have been increasing steadily, yet is not the subgroup of young women. This study focuses on classical and novel risk factors of cardiovascular disease in young women compared with older women.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

1. Atherosclerotic Cardiovascular Disease Novel and Traditional Risk Factors in Middle Eastern Young Women. The ANCORS-YW Study.
   Hammoudeh AJ, Jallad M, Khader Y, Badaineh Y, et al · · 2024 · cited 6× · PMID 39035774 · DOI 10.5334/gh.1341
2. Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) Study.
   Hammoudeh AJ, Aldalal'ah M, Smadi EA, Alrishoud D, et al · · 2025 · cited 3× · PMID 39931041 · DOI 10.2147/vhrm.s499355
3. Traditional and Non-Traditional Risk Factors of Acute Coronary Syndrome in Young Women: Evidence from the ANCORS-YW Study.
   Ibdah R, Al-Nusair M, Abuhalimeh R, Mahmoud SA, et al · · 2025 · cited 1× · PMID 39876840 · DOI 10.2147/ijwh.s479229
4. Coexistence of Standard Modifiable, Other Classical, and Novel and Classical Atherosclerotic Cardiovascular Disease Risk Factors in Middle Eastern Young Women.
   Al-Shudifat AE, Hammoudeh AJ, Al Saud W, Ibdah R, et al · · 2024 · cited 1× · PMID 39005236 · DOI 10.2147/vhrm.s468209
5. Non-HDL Cholesterol and Residual Cardiometabolic Risk in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease
   Alkouri O, Al-Bashaireh A, Alobaidly A, Alharbi G, et al · · 2026
6. Association of SMuRFs with cardiovascular risk factors, disease burden, and pharmacological management in Middle Eastern patients with ASCVD and a family history of premature CVD.
   Alrida NA, Albikawi Z, Alotaibi N, Alkouri O, et al · · 2025 · PMID 41393265 · DOI 10.3389/fcvm.2025.1678767
7. Prevalence of physical activity and its association with atherosclerotic cardiovascular risk factors in young women in the middle east: a sub-analysis of the ANCHORS study.
   Alkouri O, Alrida NA, Alabkal RM, Khader Y, et al · · 2025 · PMID 41034877 · DOI 10.1186/s12889-025-24595-y
8. Stratifying atherosclerotic cardiovascular disease by SMuRF burden in a Middle-Eastern country: A multiregistry study of demographics, comorbidities, and therapeutic trends.
   Alkouri O, Albikawi Z, Saifan AR, Khatatbeh H, et al · · 2025 · PMID 40982559 · DOI 10.1371/journal.pone.0332302